Get started

Aurobindopharma

AUROPHARMA: Terminal ThrustUsually this wave structure forms in an impulsive sequence as wave 4 . It consists of 5 sub waves as wave-a , wave-b , wave-c, wave-d and a final setback wave-e . Each of these waves consists of three wave internal structure. Each of the waves should not break their extreme points. The final confirmation to enter the position comes when the price gets close above the level of wave-d. The minimum target of the pattern is just a poke above the level of wave-b and just above the level of wave-3 of the impulsive count. There is also a guideline to predict the target of this pattern which is known as triangular thrust. The triangular thrust is the measurement of the distance from the level of wave-a to the level of wave-b . This measured length should be kept at the point of completion of wave-e (conservative approach) or to the breakout level of wave-d to get the target of this pattern (aggressive approach). Triangles are the penultimate waves i.e. waves before the last wave. This suggests that prices have reached to level of exhaustion and are likely to take a reversal. In this particular case, Auropharma is likely to finish the Wave-3. A break of the green trendline will give the first signal that wave-3 has peaked. Trading strategy: Sell below 630 keeping Sl of the previous high before breaking the 630 on the downside and look for the target of 600/585 in the coming days/weeks.
NSE:AUROPHARMAShort
by TradingSutra
1
AuroPharma @ Long Position Trade..Aurobindo Pharma Looking Good For Short Term Positional long Trade @CMP 560. Taken Support from Trendline & Forming a Base With Low Selling Volume From left Side to Right Side Chart Pattern.. Looks Like Accumulation Process is Done ,, Now We can Expect Participation Stage to come. Plus NIfty Pharma Sector Looking Strong... Long @560 // SL 525/ T1--600---T2--628---T3--640-670++++ Trade Duration of 1 to 2 months .. This Trade Has Low Risk and high Return Possibility This call is just for study Purpose. Do invest at your own Risk .. STAY SAFE : Stay WEALTHY:::
NSE:AUROPHARMALong
by NawazShaikh137
Higher Highs and Higher Lows - Recovery?Aurobindo Pharma has been trading at a steep discount to its ATH recently. Its recent quarterly earnings, and decisions regarding acquisitions and then their cancellation were not perceived well by the market. After a long period of Lower Highs and Lower Lows, The share seems to be making Higher Highs and Higher Lows now in recent 2 waves. I am curious to see if it can create a turnaround here. It is only for educational purposes and not an Investment Advice
NSE:AUROPHARMA
by Aayush_Rungta
Aurobindo Pharma Technical and Fundamental AnalysisTechnical Analysis Aurobindo Pharma has taken support at upper range of support box(630). It can move upwards after taking support at 630 price level. It is good time to accumulate share at current levels for long term. Fundamental Analysis Current PE : 7.45 (Undervalued in comparison to peer Pharma stocks) Sector PE : 38.7 Below data for previous 5 years. Revenue Growth : 15.2% Sector Revenue Growth : 6.96% Market share increased from 7.65% to 11% Net income growth : 21.4% Sector Net income growth : 8%
NSE:AUROPHARMALong
by k2iadvisory
1
Aurobindo Pharma - LongAurobindo Pharma - Long Buy : ₹ 697 - ₹ 730 Target: ₹ 768.05, ₹ 853.15, ₹ 903.6, Support: ₹ 673.5 Trade and Invest Wisely with your own knowledge! Good Luck! You can also see my other stock analysis and the results in my profile ideas. Please follow me , If you would like to see more ideas on winning stocks. **Disclaimer: I am NOT a SEBI registered consultant/Advisor. It is completely my view and opinion. My intention is not to provide any financial advice, training advice, or any type of advices or any recommendations on stock/Forex/Coin buying or selling. Please do your own research and consult with your financial advisor before taking any action. I am not responsible for any of your action on buying or selling or holding the above mentioned stock or/and index or/and Forex or/and coins . ***
NSE:AUROPHARMALong
by pmosesoliver